Skip over navigationPharmaceutical Preparation Mfg | Pharmaceuticals & Biotechnology > Pharmaceuticals Industry | Business solutions from AllBusiness.com
Tokyo, Feb 9, 2012 - (JCN Newswire) - Eisai Co. Ltd entered into an asset purchase agreement with Robert Bosch GmbH (Bosch Group) on February 8, 2012 concerning the transfer of the entire...
Tokyo, Feb 7, 2012 - (JCN) - Asahi Kasei Pharma Corp. recently filed an application for approval of the antiviral agent Famvir, which was developed in Japan jointly with Maruho Co. Ltd, for...
HIGHLAND PARK, N.J., Feb. 1, 2012 (SEND2PRESS NEWSWIRE) -- 2012 marks an important milestone for Belvidere Pharmacy. It opened new doors in its new hometown of Highland Park. When owner and President Shara...
In SHARP, VYTORIN 10/20 mg lowered LDL cholesterol in patients with moderate to severe chronic kidney disease, or CKD, and major vascular events were reduced in the treatment group compared to placebo. The...
The company has also announced the assignment of US co-promotion rights to AQUORAL, an FDA-cleared, prescription-only spray for the treatment of Xerostomia, or the medical term for dry mouth due to a lack...
Matricaria will oversee the implementation of a new management structure under which Joseph F. Woody has been appointed president and CEO of KCI and Lisa N. Colleran has been appointed president and CEO...
Tokyo, Jan 31, 2012 - (JCN) - In line with its commitment to support the World Health Organization's lymphatic filariasis elimination program, Eisai Co., Ltd, as one of the 13 major research and...
NovaDel Pharma, Inc., a specialty pharmaceutical company, has terminated license agreement with Talon Therapeutics, Inc. (formerly Hana Biosciences, Inc. ) and Par Pharmaceutical Companies, Inc., for Zensana. Talon is a biopharmaceutical company, while...
The Medicines Company (MDCO) has settled the lawsuits filed in the US district court for the district of Delaware relating to the Abbreviated New Drug Application (ANDA) filed by APP Pharmaceuticals, LLC (APP)...
NovaDel Pharma, Inc., a specialty pharmaceutical company, has terminated its license agreements with Talon Therapeutics, Inc. (formerly Hana Biosciences, Inc. ) and Par Pharmaceutical Companies, Inc., for Zensana. Talon is a biopharmaceutical company,...
A Bridgewater specialty pharmaceutical firm says it will run out of money by the end of the month if it doesn't find a buyer, investor or other partnership deal. NovaDel Pharma Inc. announced...
Banking Sussex Bank, in Franklin, has appointed Adriano M. Duarte to first vice president/treasury manager. He previously held manager roles in the accounting and financial reporting areas at Investors Bank. He holds a...
Eli Lilly and Co. is pouring more money than ever into its research and development pipeline, but Wall Street has been rewarding companies that cut such spending, according to a recent report by...
A key part of founding a company is knowing when to quit. Persistence is an admirable trait, says Michael Robertson, who has founded several companies. However, "there's a fine line between persistence and...
Janssen Research & Development LLC, a pharmaceutical subsidiary of New Brunswick, N.J.-based Johnson & Johnson, recently opened the doors of its 30,000-square-foot life science innovation center in Torrey Pines Mesa. The center, Janssen...
CAMBRIDGE, Mass. -- Millennium: The Takeda Oncology Company today announced it has been named among the 100 Best Companies to Work For in the United States by FORTUNE. This is the second consecutive...
RESEARCH TRIANGLE PARK, N.C. -- BioCryst Pharmaceuticals, Inc., (NASDAQ:BCRX) today announced that Nancy J. Hutson, Ph.D. was elected to the Company's Board of Directors, effective Friday, January 20, 2012. "We are excited to...
Latest Revenue Milestone Built on High Demand for Business Analytics to Capitalize on Big Data CARY, N.C. -- SAS, the leader in business analytics software and services, achieved record global revenue of US$2.725...
DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/ec4c56/the_outlook_for_ph) has announced the addition of the "The Outlook for Pharmaceuticals Worldwide" subscription to their offering. Original, Respected And Reliable Market Reports That Provide Critical Business Insights To...
Stony Brook University has entered into a multiyear research partnership with the global pharmaceutical company Sanofi to develop a potential treatment for tuberculosis and other bacterial infections. The university didn't disclose the terms...